Securing Americans’ Genetic Information: Privacy and National Security Concerns Surrounding 23andMe’s Bankruptcy Sale

Immigration Enforcement and Sanctuary PoliciesHouse Oversight and Government Reform · 2025-06-10 · 119th Congress
The House Oversight and Government Reform Committee convened this hearing to examine what happens to the genetic data of 23andMe's roughly 15 million customers as the company proceeds through Chapter 11 bankruptcy, with Regeneron Pharmaceuticals and TTAM Research Institute (founded by former CEO Anne Wojcicki) as the two remaining bidders. Begins at 0:17:12
Transcript
Highlights

Title

23andMe bankruptcy sale raises genetic data privacy and security concerns

Purpose

The House Oversight and Government Reform Committee convened this hearing to examine what happens to the genetic data of 23andMe's roughly 15 million customers as the company proceeds through Chapter 11 bankruptcy, with Regeneron Pharmaceuticals and TTAM Research Institute (founded by former CEO Anne Wojcicki) as the two remaining bidders. Members questioned 23andMe's interim CEO, board member Anne Wojcicki, and a law professor about past foreign investment ties, the 2023 data breach, and whether existing federal law adequately protects sensitive genetic information from foreign adversaries, insurers, and law enforcement. Begins at0:17:12

Who spoke

Chairman James Comer (R-KY)0:17:12: Opened by outlining the bankruptcy timeline, Regeneron's May 19 asset purchase agreement and the June 4 reopened auction with TTAM0:18:01; cited 23andMe's 2015 funding from Wuxi Healthcare Ventures, tied to the CCP and PLA0:19:12, and the 2023 breach exposing ~7 million profiles0:19:55; later pressed Wojcicki on whether Oracle's Larry Ellison is backing her bid, which she denied3:38:59.

Ranking Member Stephen Lynch (D-MA)0:22:11: Said 23andMe operates with minimal oversight compared to HIPAA-covered entities0:22:43; argued DOGE's dismantling of federal cybersecurity staff and consolidation of government data poses a greater privacy threat0:25:270:26:25.

Anne Wojcicki, 23andMe co-founder/board member and bidder0:30:11: Testified over 80% of customers opted into research0:31:34; said her data-driven bid is exclusively her own, addressed later3:39:00; confirmed deleted data is destroyed and irreversible2:14:07; said Wuxi's $10 million investment came with no board seat or data access2:59:38; declined to say TTAM's backer is anyone but herself3:39:00.

Joe Selsavage, interim CEO of 23andMe0:36:16: Said the company has two remaining bidders, both American enterprises0:40:15; detailed post-breach security steps including forced password resets and mandatory two-factor authentication1:03:07; said 1.9 million customers (~15%) requested data deletion since the bankruptcy announcement1:23:04; confirmed the special committee has ruled out selling to China, Russia, North Korea, or Iran2:23:50; acknowledged the company cannot guarantee no one else has ever accessed customer data1:25:39.

Prof. Margaret Hu, William & Mary Law School0:41:31: Argued genetic and biometric data are now central to "AI warfare" and national security0:42:39; called for a comprehensive federal regulatory framework similar to the FAA's oversight role0:44:01; warned that de-identified genetic data can be re-identified with minimal additional information2:17:58.

Rep. Eleanor Holmes Norton (D-DC)1:04:05: Detailed DOGE's cuts to the U.S. Digital Service and reported plans to cut IT staff at the Social Security Administration and IRS1:07:011:08:42; entered a resignation letter from USDS engineers into the record1:06:32.

Rep. Virginia Foxx (R-NC)1:10:26: Asked how 23andMe prevents CCP misuse of genetic data and whether anything could have prevented the 2023 breach1:10:521:14:28.

Rep. Shontel Brown (D-OH)1:15:26: Asked what concrete security steps followed the 2023 breach and what Congress should do given the lack of a federal biological-data framework1:16:241:18:53.

Rep. Gary Palmer (R-AL)1:20:13: Pressed Wojcicki on the 2018 and 2023 GSK data-sharing partnerships and how aggressively customers were notified of opt-out rights, which she called "not that aggressive"1:21:43; asked about the 27-state AGs' motion for a bankruptcy ombudsman/security examiner, which Selsavage said the company supports1:25:09.

Rep. Melanie Stansbury (D-NM)1:26:37: Linked the hearing to a pending House proposal to preempt state AI/data privacy laws, calling it contradictory to protecting 23andMe customer data1:27:19.

Rep. Glenn Grothman (R-WI)1:32:10: Asked Hu why customers should care about genetic data exposure, citing AI-driven targeting and cognitive warfare risks1:32:41; confirmed with Selsavage that data can remain on Amazon servers indefinitely absent deletion requests1:34:30.

Rep. Emily Randall (D-WA)1:37:42: Asked what entities fall outside existing federal health-data law and how withdrawn Biden-era HIPAA reproductive-health guidance affects risk1:38:391:40:28.

Rep. Scott Perry (R-PA)1:42:54: Questioned whether customers are told their data may be used commercially, and pressed Wojcicki on 23andMe's moral obligations regarding potential CCP partnerships1:47:26.

Rep. Suhas Subramanyam (D-VA)1:48:29: Noted the bankruptcy notice is not prominent on 23andMe's website and asked whether a buyer could resell data to further third parties; Selsavage confirmed yes under current consents1:51:19.

Rep. Anna Paulina Luna (R-FL)1:53:40: Confirmed with Wojcicki that deleted data is permanently and irreversibly destroyed1:54:07.

Rep. Summer Lee (D-PA)1:55:03: Asked Hu about gaps in privacy law given AI, and pressed Selsavage on the vague "other legally valid requests" language allowing law-enforcement data sharing1:57:47.

Rep. Tim Burchett (R-TN)1:59:56: Confirmed Wuxi Healthcare Ventures invested $10 million of a $115 million round with no board control2:00:44; cited his own American Genetic Privacy Act (HR 2286) and criticized Congress for inaction due to lobbying2:01:38.

Rep. Rashida Tlaib (D-MI)2:05:08: Framed the issue as part of a broader "surveillance state," including grocery pricing and NSA surveillance, and pressed Hu on preventing corporate misuse of genetic data for insurance discrimination2:06:36.

Rep. Eric Burlison (R-MO)2:10:44: Asked Hu about the street value of stolen medical records (over $50,000)2:11:28 and had Selsavage explain the "credential stuffing" mechanism behind the 2023 breach2:12:27.

Rep. Ayanna Pressley (D-MA)2:16:08: Pressed Wojcicki on whether de-identified genetic data can be re-linked to individuals (yes)2:17:28; demanded Selsavage commit to an opt-in consent requirement before any data transfer in the sale, which he declined to promise unconditionally2:19:37.

Rep. Morgan McGarvey (R-VA): Not identified as speaking (no distinguishable segment in transcript).

Rep. Dan Meuser (R-PA)2:26:33: Reviewed 23andMe's terms of service, establishing that the company does not own customer genetic data and cannot sell it to third parties like Goldman Sachs or a foreign government2:29:17; pressed Selsavage on why the company won't adopt an opt-in policy before sale2:30:41.

Rep. Marjorie Taylor Greene (R-GA)2:40:22: Questioned Wojcicki about 23andMe's past social media posts on transgender pronouns, abortion, and gender-affirming care, calling the positions inconsistent with the company's DNA-based science2:41:22.

Rep. Mark Alford (R-MO)2:45:23: Discussed disaster-fraud vulnerability in Missouri following storms and asked Hu how data exposure compounds risk to vulnerable communities, then criticized DOGE and Elon Musk2:47:02.

Rep. Andy Biggs (R-AZ)2:49:37: Established that customers legally "own" their genetic data under license/consent arrangements, and that 23andMe would bear liability for violating that consent2:50:082:51:35.

Rep. William Timmons (R-SC)2:56:08: Raised the bioweapon-targeting risk from large DNA databases (23andMe's ~15 million vs. Ancestry's ~25 million)2:56:35; noted Wuxi had no board seat2:59:38.

Rep. Maxwell Frost (D-FL)3:01:48: Cited Pew data that under 10% of people read terms of service3:03:00; asked Hu about state-level models like Colorado's AI consumer protection act3:05:27.

Rep. Pete Sessions (R-TX)3:06:40: Asked who ultimately decides the winning bidder (the bankruptcy court, based on a special-committee recommendation)3:07:11; asked whether 23andMe can proactively re-contact customers about new research findings tied to their data3:08:42.

Rep. Eli Crane (R-AZ)3:12:38: Asked why Jewish and Chinese-heritage customers were reportedly targeted in the 2023 breach3:12:38; pressed both witnesses on why they couldn't commit to letting customers opt back in before a sale3:14:17.

Chairman Comer (second round)3:18:38: Cited data-breach statistics (3,200+ U.S. breaches in 2023, 353 million people affected) and questioned whether lab workers, including Chinese nationals at LabCorp, handled customer DNA data3:19:353:20:37.

Rep. Jasmine Crockett (D-TX)3:23:39: Criticized DOGE for aggregating federal data without proper notice3:24:16; noted she never submitted her own DNA to any service due to historical mistrust3:28:38.

Rep. Craig Goldman (R-TX)3:29:47: Questioned Wojcicki about 23andMe's past social media posts on gender pronouns and bathroom-access policy, arguing it contradicted the company's genetics mission3:30:00.

Ranking Member Lynch (closing)3:38:29: Closed by reiterating that no comprehensive federal law limits data sales and criticizing Republican colleagues for focusing on transgender issues rather than DOGE's handling of federal data3:36:09.

Key moments

Wojcicki testified that a customer's BRCA1 result from 23andMe led to early breast cancer detection, reading aloud a customer's thank-you email0:33:44.

Selsavage confirmed the two final bankruptcy bidders are Regeneron Pharmaceuticals and TTAM Research Institute, both American entities, and that the special committee has ruled out any sale to China, Russia, North Korea, or Iran0:40:152:23:50.

Comer stated 23andMe received $115 million in 2015 funding including $10 million from Wuxi Healthcare Ventures, a firm with ties to the CCP and PLA; Wojcicki confirmed the investment but said the company was unaware of those ties at the time and Wuxi had no board seat or data access0:19:122:00:44.

Selsavage disclosed that approximately 1.9 million customers (about 15%) requested account/data deletion since the bankruptcy announcement, and that deletion is processed within a reasonable timeframe1:23:041:35:30.

Rep. Palmer got Wojcicki to admit the company was "not that aggressive" in notifying customers before sharing aggregate genetic data with GlaxoSmithKline in 2018 and again after a 2023 expansion of that partnership1:21:43.

Under questioning from Rep. Meuser, Selsavage confirmed 23andMe's terms of service state the company does not own customers' genetic or health data, yet the same terms allow that data to transfer to a new owner in a bankruptcy sale — a discrepancy Meuser pressed as contradictory2:28:472:29:58.

Rep. Pressley pressed Selsavage to commit to a new opt-in consent process before any data transfer to a buyer; he repeatedly declined to give a yes/no commitment, citing existing consents and notice emails2:19:372:20:27.

Selsavage described the 2023 breach as "credential stuffing" rather than a direct system breach — attackers used previously leaked passwords from other websites to access accounts and harvest DNA Relatives data1:02:442:12:27.

Hu testified that de-identified genetic data can be re-identified with minimal additional information such as zip code or gender, undermining claims of anonymization2:17:58.

Rep. Marjorie Taylor Greene and later Rep. Goldman questioned Wojcicki extensively about past 23andMe social media posts on transgender pronouns, bathroom access, and gender-affirming care for youth, arguing these positions were inconsistent with the company's genetics-based mission; Wojcicki said she could not recall details of specific posts2:40:223:30:00.

Metadata

CommitteeHouse Oversight and Government Reform
Chamber / CongressHouse · 119th Congress
Date2025-06-10
TypeHearing
Witnesses
Ms. Margaret Hu — Professor of Law, William & Mary Law School
Mr. Joe Selsavage — Interim CEO, 23andMe, Inc.
Ms. Anne Wojcicki — Board Member, 23andMe, Inc.
Videoyoutube
Transcript448 caption blocks · 31,601 words · 3:40:47 runtime
EventCongress.gov 118362